Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial)

医学 预防性头颅照射 传统PCI 内科学 危险系数 肿瘤科 肺癌 累积发病率 人口 间变性淋巴瘤激酶 脑转移 临床终点 随机对照试验 临床研究阶段 置信区间 移植 心肌梗塞 恶性胸腔积液 环境卫生
作者
Oscar Arrieta,Federico Maldonado,Jenny G. Turcott,Zyanya Lucia Zatarain-Barrón,Feliciano Barrón,Monika Blake-Cerda,Luis Cabrera-Miranda,Andrés F. Cardona,Jaime de la Garza,Rafael Rosell
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:110 (5): 1442-1450 被引量:7
标识
DOI:10.1016/j.ijrobp.2021.02.044
摘要

Purpose

To date, studies regarding the use of prophylactic cranial irradiation (PCI) versus standard of care (SoC) for patients with non-small cell lung cancer (NSCLC) have not shown a significant effect in terms of overall survival (OS). Additionally, the effect of PCI among high-risk patients has been scarcely studied. The objective of this randomized phase 2 study was to evaluate the role of PCI in a population of patients at high risk for development of brain metastases (BM).

Methods and Materials

Eligible patients had histologically confirmed NSCLC without baseline BM, harboring epidermal growth factor receptor mutations, anaplastic lymphoma kinase rearrangements, or elevated carcinoembryonic antigen levels at the time of diagnosis. Participants received systemic therapy according to molecular status, those without progressive disease were then assigned to receive SoC or SoC + PCI (25 Gy in 10 fractions). The primary outcome was cumulative incidence of brain metastases (CBM). The secondary endpoints included progression-free survival and OS. Quality of life and neurocognitive function are discussed in a separate article (Clinicaltrials.gov: NCT01603849).

Results

From May 2012 to December 2017, 84 patients were enrolled in the study, with 41 patients allocated to receive PCI and 43 received SoC. Patients allocated to receive PCI had a CBM at 24 months of 7% versus 38% in those allocated to the SoC arm. PCI was associated with a hazard ratio of 0.12 (95% confidence interval, 0.035-0.42) for developing BM. A benefit in OS was also observed (64.5 vs 19.8 months; hazard ratio: 0.41 (95% confidence interval, 0.22-0.78; P =∙007).

Conclusions

Among a selected population at high risk for developing BM, PCI significantly decreased CBM in addition to increasing progression-free survival and OS. To our knowledge, this is the first study to evaluate PCI in epidermal growth factor receptor mutations, anaplastic lymphoma kinase rearrangements, or elevated carcinoembryonic antigen levels in patients with NSCLC, showing a significant improvement in CBM. This relevant information should be of particular importance in the context of patients without access to third-generation targeted agents. Further studies are warranted to ascertain this effect.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐应助小小K采纳,获得10
1秒前
2秒前
斯文败类应助llwxx采纳,获得10
2秒前
2秒前
2秒前
2秒前
完美世界应助庾稀采纳,获得10
3秒前
hjb发布了新的文献求助20
3秒前
4秒前
傻傻的寄翠完成签到,获得积分10
5秒前
pluto应助Chao采纳,获得30
5秒前
Lucas应助CC采纳,获得10
5秒前
耶豆发布了新的文献求助10
5秒前
瓜子发布了新的文献求助20
5秒前
李健的小迷弟应助lanmo采纳,获得10
7秒前
keyanxiaobai发布了新的文献求助10
7秒前
可爱的函函应助LNN采纳,获得10
7秒前
ColinWine发布了新的文献求助10
7秒前
7秒前
8秒前
SciGPT应助武雨寒采纳,获得10
8秒前
10秒前
11秒前
橙子发布了新的文献求助10
12秒前
懒洋洋发布了新的文献求助20
12秒前
orixero应助徐福采纳,获得10
12秒前
小小K发布了新的文献求助10
13秒前
13秒前
14秒前
15秒前
15秒前
yeahsawyou发布了新的文献求助10
15秒前
18秒前
scsc完成签到,获得积分10
18秒前
初夏发SCI发布了新的文献求助10
19秒前
orixero应助澡雪采纳,获得10
19秒前
JamesPei应助小小K采纳,获得10
20秒前
CodeCraft应助glitter采纳,获得30
20秒前
25秒前
Ava应助大白采纳,获得10
25秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975836
求助须知:如何正确求助?哪些是违规求助? 3520174
关于积分的说明 11201364
捐赠科研通 3256576
什么是DOI,文献DOI怎么找? 1798362
邀请新用户注册赠送积分活动 877539
科研通“疑难数据库(出版商)”最低求助积分说明 806426